Recalls / Firms / Hospira Inc. A Pfizer Company
Hospira Inc. A Pfizer Company
8 FDA drug recalls on record — 2 Class I.
| Date | Class | Drug | Status |
|---|---|---|---|
| 2018-02-20 | Class II | Labetalol Hydrochloride | Terminated |
| 2017-07-06 | Class III | Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 5 mL Single-use vial, Rx Only, Sterile, M | Terminated |
| 2017-05-18 | Class II | Levophed | Terminated |
| 2017-02-10 | Class II | METRONIDazole Injection, USP 500 mg (5 mg/mL) in 100 mL Single Dose Flexible Container, Rx | Terminated |
| 2017-01-24 | Class I | Vancomycin Hydrochloride for Injection, USP, 10 grams, Pharmacy Bulk Package - Not For Dir | Terminated |
| 2016-09-16 | Class II | Marcaine | Terminated |
| 2016-09-16 | Class II | Marcaine | Terminated |
| 2016-08-04 | Class I | Bupivacaine Hydrochloride | Ongoing |